Literature DB >> 3880547

Identification of insulin variants in patients with hyperinsulinemia by reversed-phase, high-performance liquid chromatography.

S Seino, A Funakoshi, Z Z Fu, A Vinik.   

Abstract

We have characterized the molecular forms of circulating insulins in patients with hyperinsulinemia of diverse etiology. We have also compared the efficacy of various chromatographic conditions using reversed-phase (RP) HPLC. Using 0.2% trifluoroacetic acid (TFA) and triethylamine (TEA) with acetonitrile as the organic modifier, at an elution rate of 0.17%/min, porcine, bovine, and human insulins could be easily separated as well as abnormal insulins in the plasma of a patient (J.R.) with hyperinsulinemia of unknown etiology. When the reversed-phase C18 column was changed and a gradient of 0.33%/min was used, the abnormal insulin in patient J.R. could not be separated. By changing the solvent system to acetonitrile and isopropanol (vol:vol, 3:1) containing 0.1% TFA, omitting the TEA, and using a gentle gradient of 0.1%/min, various semisynthetic analogues of human insulin could be easily separated and the abnormal insulin could be identified in the plasma of the patient J.R. Abnormal insulin was also found in a patient with MEN-I, but in contrast, the insulins in eight patients with benign sporadic insulinomas appeared to be normal. These results suggest that certain hyperinsulinemic states may be associated with an abnormal insulin and that RP-HPLC is useful for identification of insulin variants in the circulation. However, the conditions of RP-HPLC may be critical if the abnormalities of the insulin are subtle.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3880547     DOI: 10.2337/diab.34.1.1

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  3 in total

Review 1.  Role of insulin in the fetus.

Authors:  R K Menon; M A Sperling
Journal:  Indian J Pediatr       Date:  1991 Jan-Feb       Impact factor: 1.967

2.  Insulin Wakayama: familial mutant insulin syndrome in Japan.

Authors:  K Nanjo; M Miyano; M Kondo; T Sanke; S Nishimura; K Miyamura; K Inouye; B D Given; S J Chan; K S Polonsky
Journal:  Diabetologia       Date:  1987-02       Impact factor: 10.122

3.  Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin.

Authors:  K Nanjo; T Sanke; M Miyano; K Okai; R Sowa; M Kondo; S Nishimura; K Iwo; K Miyamura; B D Given
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.